M.D. Anderson Cancer Center: all 3,044 studies

Page 21 of 31. Open to participants first (578), then studies with results posted, then the rest; newest registration first within each.

• Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy SurgeryActive, not recruitingNCT03128866Early Phase 1
• Pneumoperitoneum Management With Low vs. Higher PressureWithdrawnNCT03128281Phase 2
• Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid LeukemiaTerminatedNCT03126864Phase 1
• Difference in the Estimation of PrognosisWithdrawnNCT03115528
• Dyadic Yoga Intervention for Patient With Head and Neck Cancer Undergoing Radiotherapy and Their Family CaregiversActive, not recruitingNCT03114501Not applicable
• Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in ChildrenWithdrawnNCT03111069Phase 1
• Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung CancerActive, not recruitingNCT03110978Phase 2
• Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG ImmunotherapyTerminatedNCT03106610Phase 1
• Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal CancerActive, not recruitingNCT03087071Phase 2
• Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate CancerActive, not recruitingNCT03085043Not applicable
• Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast CancerSuspendedNCT03077841Phase 2/3
• Atezolizumab and Bevacizumab in Treating Patients With Rare Solid TumorsActive, not recruitingNCT03074513Phase 2
• Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal MelanomaActive, not recruitingNCT03068624Phase 1
• Poziotinib in EGFR Exon 20 Mutant Advanced NSCLCTerminatedNCT03066206Phase 2
• Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS MutationTerminatedNCT03065387Phase 1
• Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung CancerActive, not recruitingNCT03059940Early Phase 1
• Coordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic CancerStatus unknownNCT03058926
• Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)Status unknownNCT03053999
• Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary HyperparathyroidismStatus unknownNCT03052075
• Registry for Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2Active, not recruitingNCT03048279
• Parathyroid Cancer Versus Atypical Parathyroid Neoplasm; Investigating Their Clinical Characteristics and Biological BehaviorCompletedNCT03046524
• Gene Expression in HyperparathyroidismTerminatedNCT03044600
• Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)Active, not recruitingNCT03043508
• Chronic Non-Malignant Pain in Cancer Patients at a Supportive Care ClinicCompletedNCT03043378
• Wearable Exercise Trackers in Cancer RehabilitationCompletedNCT03042884Not applicable
• Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing SurgeryCompletedNCT03038152Phase 4
• Impact of a Systematic Social Work Driven Approach on Medical Power of Attorney Documentation, Knowledge, Attitudes, and Beliefs in Participants With Stage I-IV Gynecological CancersCompletedNCT03037346Not applicable
• Comprehensive Nutritional Geriatric Assessments in Identifying Malnutrition in Older Cancer ParticipantsActive, not recruitingNCT03035604
• Communication Strategies to Introduce Psychology ServicesCompletedNCT03035448Not applicable
• Neoadjuvant Listeria or Daratumumab in Prostate CancerWithdrawnNCT03035357Phase 2
• Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal MetastasesActive, not recruitingNCT03028337Phase 2
• Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver CancerActive, not recruitingNCT03028311Phase 1
• Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal DiseaseActive, not recruitingNCT03025256Phase 1
• Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell TransplantActive, not recruitingNCT03023631Phase 4
• Brief Guided Relaxation for Women Undergoing Stereotactic Breast BiopsyCompletedNCT03023215Not applicable
• Sapanisertib and Metformin in Treating Patients With Advanced or Metastatic Relapsed or Refractory CancersCompletedNCT03017833Phase 1
• Hypnosedation in Relaxing Patients Undergoing Breast Cancer SurgeryActive, not recruitingNCT03012399Not applicable
• A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial CarcinomaActive, not recruitingNCT03008408Phase 2
• Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by SurgeryActive, not recruitingNCT03007030Phase 2
• MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT03004105Phase 2
• 68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine TumorsTerminatedNCT03001349Early Phase 1
• Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)SuspendedNCT02993068Not applicable
• Trial of Quercetin in the Treatment and Prevention of Chemotherapy-induced Neuropathic Pain in Cancer PatientsWithdrawnNCT02989129Early Phase 1
• Meditation Therapy in Improving Anxiety and Depression in Cancer Patients With Psychosocial DistressActive, not recruitingNCT02988271Not applicable
• Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal CancerActive, not recruitingNCT02983578Phase 2
• CBCT in Guiding Bronchoscopy in Patients With Lung LesionsCompletedNCT02978170Not applicable
• Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by AnthracyclinesSuspendedNCT02962661Phase 1
• Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed LymphomaWithdrawnNCT02961816Phase 2
• Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02960646Phase 1
• Isatuximab With or Without Lenalidomide in Patients With High Risk Smoldering Multiple Myeloma (ISAMAR)Active, not recruitingNCT02960555Phase 2
• Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During an Outpatient Palliative Care VisitCompletedNCT02957565Not applicable
• Study of Ibrutinib Followed by Ibrutinib in Combination With Nivolumab in Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT02950038Phase 2
• PD 0360324 and Cyclophosphamide in Treating Patients With Recurrent High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerWithdrawnNCT02948101Phase 2
• A Culturally Sensitive Social Support InterventionCompletedNCT02946697Not applicable
• Health Literacy and Smoking Cessation in Low-SES Diverse Smokers - Project HALT IIWithdrawnNCT02942212Early Phase 1
• Study of Ixazomib and Erlotinib in Solid TumorsCompletedNCT02942095Phase 1
• Pembrolizumab and Paricalcitol With or Without Chemotherapy in Patients With Pancreatic Cancer That Can Be Removed by SurgeryCompletedNCT02930902Phase 1
• High-Intensity Interval Training for Women at Heightened Risk for Breast CancerCompletedNCT02923401Not applicable
• Lenvatinib and Capecitabine in Patients With Advanced MalignanciesWithdrawnNCT02915172Phase 1
• Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast CancerActive, not recruitingNCT02912312Phase 2
• Expectations Regarding Mobility and Self-CareActive, not recruitingNCT02911064
• Nivolumab With Trametinib and Dabrafenib, or Encorafenib and Binimetinib in Treating Patients With BRAF Mutated Metastatic or Unresectable Stage III-IV MelanomaActive, not recruitingNCT02910700Phase 2
• Supervised Exercise in Improving Physical Fitness Before Surgery in Patients With Resectable Bone CancerActive, not recruitingNCT02893397Not applicable
• Early Metabolic Support as a Potential Solution to Multi-Organ Dysfunction Syndrome (MODS) During Severe SepsisWithdrawnNCT02885688Phase 2
• FDG PET Imaging in Diagnosing Patients With GlioblastomaCompletedNCT02885272Early Phase 1
• Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look SurgeryActive, not recruitingNCT02884648Phase 2
• Arginine in Treating Patients With Anti-VEGF Induced Kidney InjuryWithdrawnNCT02882373Phase 2
• Molecular Determinants of Response to Preoperative Therapy in Patients With Locally Advanced Colorectal CancerStatus unknownNCT02877056
• Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast CancerActive, not recruitingNCT02876107Phase 2
• Circulating Tumor Cells in Patients With Locally Advanced Rectal CancerActive, not recruitingNCT02874885
• Young-Onset Colorectal CancerActive, not recruitingNCT02863107
• Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell TransplantActive, not recruitingNCT02861417Phase 2
• Atezolizumab, Obinutuzumab, and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Relapsed or Refractory Richter SyndromeActive, not recruitingNCT02846623Phase 2
• The Beans to Enrich the Gut Microbiome vs. Obesity's Negative Effects (BE GONE) TrialActive, not recruitingNCT02843425Not applicable
• Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML)WithdrawnNCT02829840Phase 1/2
• Non Invasive Oral Cancer Screening Among HIV Infected IndividualsCompletedNCT02823847Early Phase 1
• Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic MelanomaCompletedNCT02816021Phase 2
• Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before SurgeryActive, not recruitingNCT02812420Early Phase 1
• Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated MalignanciesWithdrawnNCT02812056Phase 1
• Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With MalignanciesCompletedNCT02804945Phase 1
• Frameless Fractionated Stereotactic Radiation in Treating Patients With Brain MetastasesCompletedNCT02798029Phase 2
• Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant DisordersActive, not recruitingNCT02790853Early Phase 1
• Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid LeukemiaTerminatedNCT02782403Phase 1
• Feasibility of the NEXT Steps Weight Loss Intervention +/- Resistance Training for Endometrial Cancer Survivors: Effect on Lean Mass & BiomarkersActive, not recruitingNCT02774759Not applicable
• Surgery in Preventing Ovarian Cancer in Patients With Genetic MutationsActive, not recruitingNCT02760849Not applicable
• CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal TumorsTerminatedNCT02757391Phase 1
• Venetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic LeukemiaActive, not recruitingNCT02756897Phase 2
• Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer TreatmentActive, not recruitingNCT02754752Phase 2
• Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Surveillance ProgramCompletedNCT02747862
• DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast CancerActive, not recruitingNCT02744053Early Phase 1
• Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur)Active, not recruitingNCT02726997Phase 1/2
• EBUS TBNA After PET/CT in Diagnosing Patients With Stage I-IIA Non-small Cell Lung Cancer Evaluated for Stereotactic Body Radiation TherapyCompletedNCT02719847
• Dose Escalation and Cohort Expansion of Safety and Tolerability Study of Intratumoral rAd.CD40L (ISF35) in Combination of Systemic Pembrolizumab in Patients With Refractory Metastatic MelanomaWithdrawnNCT02719015Phase 1/2
• Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic MalignanciesWithdrawnNCT02718755Phase 2
• Effects of Social Networking on Chronic Disease Management in ArthritisCompletedNCT02717403Phase 2/3
• Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal CordActive, not recruitingNCT02713269Phase 2
• Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic ImmunotherapyCompletedNCT02710253Phase 2
• Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate CancerActive, not recruitingNCT02703623Phase 2
• Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed LymphomaWithdrawnNCT02701673Phase 1/2
• Radiation Therapy in Treating Patients With Recurrent Brain Tumors Who Have Undergone Previous Radiation TherapyActive, not recruitingNCT02698254Not applicable

← M.D. Anderson Cancer Center overview and focus areas